Gwynneth Thomas, PhD
Gwynneth has spent her career at the intersection of business and science, with experience in product growth, operations and fundraising. She has worked with 50+ human health startups as they worked through various strategic business decisions. For several of those startups she led fundraising efforts, collectively helping them raise over $20M. She has also functioned in various roles within startup companies, including serving as the Director for Scientific Operations for the human microbiome company Diversigen, which was sold to Orasure in 2019. She has a strong focus on commercialization with experience in the areas of genomics, digital health, medical device and diagnostics. Gwynneth holds a PhD in Molecular Pathology and a Masters of Business Administration from Wake Forest University in Winston Salem, NC.
Dr. Antonio Benitz
Tony is a Senior Advisor at Stonehaven Consulting. He retired from Boehringer-Ingelheim after a 35-year career in animal health. Tony served in senior roles in research and development in several companies, including Global Head of R&D for Pharmacia Animal Health and Novartis Animal Health. He played a key role in the integration of the R&D organizations following the acquisitions by Pfizer Animal Health and Elanco, respectively.
His experience includes bringing a range of new therapeutics and vaccines for animals to the market, and working closely with regulatory agencies in many international markets, including the Center of Veterinary Medicine, and the Food and Drug Agency in the U.S.
Jarne has over 30 years of experience in a variety of managerial roles, including ICT, Life Science and Medtech. He has extensive venture capital experience having run and managed three Danish venture funds with 24 portfolio companies, working with entrepreneurs and developing start-up and early-stage growth companies towards exit.
Jarne was Chairman of Scandinavian Micro Biodevices, an animal health company, helping them grow and finally divesting them to Zoetis. He has a strong network in the European venture capital community. In his role as CEO of Stonehaven Incubate, he develops existing portfolio companies and provides new syndication partners for the company.
Malcolm is the CEO of Agile Sciences. Prior to this he was president and CEO of Arbovax, a biotechnology company commercializing a unique and innovative platform technology that can be used to make vaccines against insect-borne viral diseases.
Prior to Arbovax he was Vice President of Operations for StemCo Biomedical and before that, was Director of International Marketing for Bayer Biologicals and Vice President of Pacific Rim Operations for Becton Dickinson Biosciences.
During his tenure with Becton Dickinson as Vice President for Asia Pacific he lived in Singapore for five years.
He started his working life as a research scientist in the biochemistry department of the Wellcome Research Laboratories in the UK.
Dr. Simon Wheeler
Simon is a veterinarian and strategic leader with over 20 years’ experience of the global animal health industry. He has previously held strategic, technical, marketing and innovation roles in various companies, including Pharmacia and Novartis.
He also reached senior positions in clinical veterinary academia in the UK and US, lecturing at international meetings and conducting research, as well as publishing three books and over 125 articles and chapters, and mentoring trainees. He has received several awards for teaching and contributions to veterinary surgery.
Simon is the CEO of animal diagnostics company, Vetsina and has recently held several consultancies, including Chief Operating Officer of Roslin Technologies, an Edinburgh-based biotech start up, and he was commercial consultant to Advanced Anaesthesia Specialists. He has supported various biotech companies as well as holding several board positions.